PER-080-02已完成未知
PHASE II STUDY: COMBINATION OF GEMCITABIN WITH CARBOPLATIN IN PATIENTS WITH REFERENCED OR RECURRENT ADVANCED EPITHELIAL OVARY CANCER
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Ovarian cancer histologically tested with evidence of recurrence or progression, which is not a tributary of curative surgery.
- •Failure to first-line therapy with regimens containing Cisplatin, up to 6 months after the suspension of treatment (including patients with maintenance treatment.) The standard for first-line treatment in ovarian cancer chemotherapy is the combination of Cisplatin and Taxol derivatives.
- •Prior homional therapy or radiotherapy (limited to the minor pelvis) should culminate 3 weeks before the administration of the study drug.
排除标准
- •Concomitante u otro tratamiento antineoplastico concomitante. Se autoriza la terapia de reemplazo hormonal, siempre que se trate de esteroides antiemeticos
- •La evidencia clinica de metastasis del sistema nervioso central (CNS)
- •Infeccion activa (a criterio del investigador)
- •Incapacidad para cumplir un seguimiento adecuado durante la duracion del estudio
- •Una segunda neoplasia maligna primaria (salvo carcinoma cervical in situ o carcinoma de la piel de celula basa) adecuadamente tratado
研究者
相似试验
进行中（未招募）
不适用
A PHASE II STUDY OF THE COMBINATION OF GEMCITABINE AND IMATINIB MESYLATE IN PRETREATED PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMAMalignant Pleural MesotheliomaEUCTR2014-002876-10-ITIstituto Clinico Humanitas
进行中（未招募）
不适用
PHASE II TRIAL OF THE COMBINATION OF GEMCITABINE AND OXALIPLATIN IN THE TREATMENT OF PATIENTS WITH METASTATIC ADENOCARCINOMA OF UNKNOWN PRIMARY SITEEstudio fase II de la combinación de gemcitabina y oxaliplatino en el tratamiento de pacientes con adenocarcinoma matastático de origen desconocido.EUCTR2005-001912-38-ESACROSS43
进行中（未招募）
1 期
PHASE II TRIAL OF THE EFFECT OF GEMCITABINE WITH INTRAVENOUS OMEGA 3 FISH OIL INFUSION IN PATIENTS WITH UNRESECTABLE PANCREATIC ADENOCARCINOMA. - FISH OIL AND GEMCITABINE IN PANCREATIC ADENOCARCINOMA - VERSION 1EUCTR2009-009470-27-GBniversity Hospitals of Leicester NHS Trust50
已完成
不适用
EOADYUVANTE PHASE 2 STUDY USING GEMCITABIN ASSOCIATED WITH DOXORRUBICINE FOR THE TREATMENT OF BREAST CANCER CLINICAL STAGE III-B-C50 Malignant neoplasm of breastMalignant neoplasm of breastC50PER-003-00ELI LILLY INTERAMERICA INC.,
已完成
不适用
A phase II study combining gemcitabine and carboplatin in patients with platinum-resistant ovarian cancerpatients with platinum-resistant ovarian cancerJPRN-UMIN000019225Osaka medical coledge30